Evidence map›Paper›PMID 26633082›Full record

ArticleAngewandte Chemie (International ed. in English)2016

Imaging Glycosylation In Vivo by Metabolic Labeling and Magnetic Resonance Imaging.

André A Neves, Yéléna A Wainman, Alan Wright, Mikko I Kettunen, Tiago B Rodrigues, Sarah McGuire, De-En Hu, Flaviu Bulat, Simonetta Geninatti Crich, Henning Stöckmann and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Imidazolium labelling permits the sensitive mass-spectrometric detection ofChemical communications (Cambridge, England) · 2021
    Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Imaging Tumor Metabolism to Assess Disease Progression and Treatment Response.Clinical cancer research : an official journal of the American Association for Cancer Research · 2016
    Review
  14. Imaging Glycosylation In Vivo by Metabolic Labeling and Magnetic Resonance Imaging.Angewandte Chemie (International ed. in English) · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 3 countries.

André A NevesCancer Research UK Cambridge Institute, Li Ka Shing Centre, Cambridge, CB2 0RE, UK. andre.neves@cruk.cam.ac.uk.ORCID http://orcid.org/0000-0003-2740-5166
Yéléna A WainmanCancer Research UK Cambridge Institute, Li Ka Shing Centre, Cambridge, CB2 0RE, UK.
Alan WrightCancer Research UK Cambridge Institute, Li Ka Shing Centre, Cambridge, CB2 0RE, UK.
Mikko I KettunenCancer Research UK Cambridge Institute, Li Ka Shing Centre, Cambridge, CB2 0RE, UK.
Tiago B RodriguesCancer Research UK Cambridge Institute, Li Ka Shing Centre, Cambridge, CB2 0RE, UK.
Sarah McGuireCancer Research UK Cambridge Institute, Li Ka Shing Centre, Cambridge, CB2 0RE, UK.
De-En HuCancer Research UK Cambridge Institute, Li Ka Shing Centre, Cambridge, CB2 0RE, UK.
Flaviu BulatDepartment of Chemistry, University of Cambridge, Cambridge, CB2 1EW, UK.
Simonetta Geninatti CrichDepartment of Molecular Biotechnology and Health Science, Molecular Imaging Center, Via Nizza 52, 10126, Turin, Italy.
Henning StöckmannDepartment of Chemistry, University of Cambridge, Cambridge, CB2 1EW, UK.
Finian J LeeperDepartment of Chemistry, University of Cambridge, Cambridge, CB2 1EW, UK.ORCID http://orcid.org/0000-0003-3408-5199
Kevin M BrindleCancer Research UK Cambridge Institute, Li Ka Shing Centre, Cambridge, CB2 0RE, UK.ORCID http://orcid.org/0000-0003-3883-6287
Cancer Research UK · GBUniversity of Cambridge · GBUniversity of Eastern Finland · FIUniversity of Turin · IT

Funding

Cancer Research UK 16465Cancer Research UK 17242
6 · The paper itself

Abstract

Glycosylation is a ubiquitous post-translational modification, present in over 50% of the proteins in the human genome, with important roles in cell-cell communication and migration. Interest in glycome profiling has increased with the realization that glycans can be used as biomarkers of many diseases, including cancer. We report here the first tomographic imaging of glycosylated tissues in live mice by using metabolic labeling and a gadolinium-based bioorthogonal MRI probe. Significant N-azidoacetylgalactosamine dependent T1  contrast was observed in vivo two hours after probe administration. Tumor, kidney, and liver showed significant contrast, and several other tissues, including the pancreas, spleen, heart, and intestines, showed a very high contrast (>10-fold). This approach has the potential to enable the rapid and non-invasive magnetic resonance imaging of glycosylated tissues in vivo in preclinical models of disease.

Indexed as

AnimalsCarbohydratesGadoliniumGlycosylationMagnetic Resonance ImagingMiceMolecular ProbesTissue DistributionCarbohydratesGadoliniumMolecular Probesbioorthogonal chemistrycancergadoliniumglycansmagnetic resonance imaging

Identifiers

PMID26633082
PMCPMC4737346
OpenAlexW2182350866

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.